Innovative Partnership for Clinical Trials
Mural Health Technologies, Inc., recognized for placing patients at the forefront of clinical trial technology, has formed a strategic partnership with ICON plc, a revered leader in healthcare intelligence and clinical research. This collaboration is a significant advancement in enhancing the experience of clinical trial participants through the integration of Mural Link, an advanced participant management and payments platform.
Improving Participant Experience
Through Mural Link, ICON aims to redefine how participant payments and interactions are managed during clinical trials. This platform offers unique functionalities, including payment solutions, travel management, and various communication tools, all designed to streamline the participant experience and significantly reduce the administrative burdens faced by site staff.
Shared Goals in Clinical Research
According to Sam Whitaker, CEO of Mural Health, the partnership arose from a mutual commitment to enhancing patient care and ensuring financial neutrality for trial participants. Both companies envision a future where various preventing barriers to participation are overcome, allowing more diverse patient populations to engage in clinical trials without the financial burden often associated with participation.
Financial Accessibility and Inclusivity
One major aspect of Mural Health's innovative model is its wide range of payment options, which includes a decision to introduce a unique fee-free debit card for participants. This initiative is expected to help eliminate financial hurdles that often discourage people from enrolling in clinical trials, especially those from underrepresented groups in clinical research.
Tangible Benefits for Healthcare Partners
Mural Health's dynamic approach to managing participant payments aligns perfectly with ICON's mission to deliver measurable benefits to their clients and patients alike. Dr. Gareth Milborrow, Executive Vice President of Business Operations at ICON, expressed optimism about this new partnership, noting how these enhancements will positively impact patient care and operational efficiencies for sites conducting clinical research.
About ICON plc
ICON plc stands as a global leader in providing healthcare intelligence and clinical research services. The organization's mission encompasses supporting pharmaceutical, biotechnology, and medical device companies with their developmental needs. With its headquarters situated in Ireland, ICON boasts a sizeable workforce of approximately 41,900 employees, working across 106 locations worldwide as of the end of the previous year.
About Mural Health
Mural Health is pioneering advancements in patient-first technology within the realm of clinical research. Its focus lies in simplifying the involvement process for patients and their caregivers. The company offers transformative solutions such as Mural Link to streamline payments and facilitate seamless participant engagement in clinical trials. Mural Health aims to enhance the overall experience of participants, reinforcing its commitment to innovation in patient care.
Frequently Asked Questions
What is the purpose of the partnership between Mural Health and ICON?
The partnership aims to enhance the participant experience in clinical trials by leveraging Mural Link's capabilities for managing payments and communication.
How does the Mural Link platform improve participant engagement?
Mural Link improves engagement by offering streamlined payments, travel coordination, communication tools, and participant satisfaction measurement.
What benefits does Mural Health's fee-free debit card provide?
The fee-free debit card eliminates financial barriers for trial participants, making it easier for them to engage in clinical research.
Who benefits from this partnership?
Both the clinical trial participants and ICON's clients benefit from improved operations and increased access to a broader patient population.
What is ICON's role in the partnership?
ICON integrates Mural Link into its operations to enhance participant management and deliver tangible benefits to patients and trial sites.
